Patents

Patents Pending

“Sustained Drug Delivery System” (US Patent Application No. 13/968,264). Inventors: Farinas, K.C., and Chamow, S.M

“Posterior segment drug delivery” (US Patent Application No. 12/696/678). Inventors: de Juan, E. Jr., Alster, Y., Chamow, S.M., Farinas, K.C., Gifford III, H.S., MacFarlane, K.A., Reich, C.J., Barrett, M., Campbell, R.E., George, R., Sutton, D. Filed 29 January 2010. Assignee; ForSight Labs LLC.

“Heterobifunctional polyethylene glycol reagents” (US Patent Application No. 12/742,423). Inventors: Zalipsky, S., Levy, D, Chamow, S.M., Zhong, Z. Filed 23 Sept 2010. Assignee; Intradigm Corporation.

“System and method for stabilizing antibodies with histidine” (US Patent Application No. 10/734,606). Inventors: Chen, B., Zapata, G., Mulkerrin, M.G., and Chamow, S.M. 11 December 2003. Assignee: Abgenix, Inc.


Patents Issued

“Sustained Drug Delivery System” (US Patent Nos. 8,535,681 and 8,530,189). Inventors: Farinas, K.C., and Chamow, S.M. 10 September 2013.

“Posterior segment drug delivery” (US Patent No. 8,399,006). Inventors: de Juan, E. Jr., Alster, Y., Chamow, S.M., Farinas, K.C., Gifford III, H.S., MacFarlane, K.A., Reich, C.J., Barrett, M., Campbell, R.E., George, R., Sutton, D. 19 March 2013. Assignee; ForSight Labs LLC.

“Carbohydrate-directed crosslinking reagents” , U.S. Patent Nos. 5,329,028, 5,605,791, 5,889,155, 5,929,211, 6,124,435, and 6,582,928 issued Jul. 12, 1994, Feb. 25, 1997, Mar. 30, 1999, Jul. 27, 1999, Sep. 26, 2000, and Jun. 24, 2003, respectively. Inventors: Ashkenazi, A.J., Chamow, S.M., and Kogan, T.P. Assignee: Genentech, Inc.
*A license was granted to Thermo Fisher Scientific (www.piercenet.com) for manufacture and commercial sale of these crosslinking reagents for biochemical research applications.

“Inhibition of heparin binding” , U.S. Patent No. 5,464,815, issued Nov. 7, 1995. Inventors: Chamow, S., Modi, N., Schwall, R., and Zioncheck, T. Assignee: Genentech, Inc.

“Method of extending the plasma half-life of deletion variants of hepatocyte growth factor” , U.S. Patent No. 5,849,689 issued December 15, 1998. Inventors: Chamow, S.M., Modi, N., Schwall, R., and Zioncheck, T. Assignee: Genentech, Inc.

“Method of extending the plasma half-life of vascular endothelial cell growth factor” , U.S. Patent No. 5,851,989 issued December 22, 1998. Inventors: Chamow, S.M., and Zioncheck, T. Assignee: Genentech, Inc.

Follow Our Blog

Sign up to get e-mail notifications of new posts.

Select a Page

Steven M. Chamow, Ph.D., Principal Consultant |
San Mateo, CA
|
650-345-1878
| info@chamowassociates.com
© 2019 Chamow & Associates |